Zalunfiban Shows Positive Phase III Results in STEMI Patients, Improves cardiac outcomes when given in pre-hospital settings

SightGlass DOT slows pediatric myopia in Canadian population

DRRA23 minutes ago 0

Court allows generic version of Roche rare disease drug to be sold in India

DRRA2 hours ago 0

FDA approves Eydenzelt as biosimilar referencing Eylea

DRRA2 hours ago 0

GLP-1 Drugs for Diabetes and Obesity Show Promise in Treating Alcohol and Drug Addiction: Study

DRRA3 hours ago 0